Serum tumour necrosis factor-alpha as a marker of disease activity in children with nephrotic syndrome
Journal of Tropical Pediatrics · 2024
DOI: 10.1093/tropej/fmae025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tropical Pediatrics, 2024. Verfasst von B C Gowtham und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Tumor Necrosis Factor-alpha, Biomarkers. Die Arbeit nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Idiopathic nephrotic syndrome (NS) is a common glomerular disease in children throughout the world; however, the exact pathogenesis of the disease remains unknown. Several studies have shown that tumour necrosis factor-alpha (TNF-α), a proinflammatory cytokine, plays a significant role in the pathogenesis of NS. The literature lacks sufficient data to establish the relationship between TNF-α and NS. This prospective study was conducted on children aged 1–14 years diagnosed with idiopathic NS. All enrolled individuals were followed up from disease onset or relapse of NS until remission or at least 42 days with steroid therapy if remission was not achieved. Serum TNF-α levels were measured at presentation and remission or after 42 days of steroid therapy if remission was not achieved. The role of TNF-α levels in response to steroid therapy in NS was also assessed. One hundred and twelve children (68% boys) with idiopathic NS were enrolled. The median age (interquartile range) at enrolment was 58.5 (37–84.7) months, while the median age at symptom onset was 47.5 (24–60.7) months. The median TNF-α level at presentation was 7.5 (3.5–12.1) pg/ml, and that at remission was 5.25 (1.62–8.8) pg/ml. The median TNF-α levels among first-episode NS at presentation were 3.98 pg/ml and 1.88 pg/ml (P = .04) at remission, whereas in steroid-resistant NS, it was 6.59 pg/ml at presentation and 9.02 pg/ml at 42 days (P = .45). There was a significant negative correlation between the duration of steroid therapy and TNF-α levels, with a correlation factor of −0.021 and R2 of 0.154 (P≤.001). Serum TNF-α levels decrease with steroid therapy in children with steroid-sensitive NS, which correlates clinically with the achievement of remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
ORCID-Profile: Lesa Dawman, Karalanglin Tiewsoh, Amit Rawat
Zitieren
APA
Gowtham, B. C., Dawman, L., Tiewsoh, K., Kushwah, S., Rawat, A., Singh, T., & Gupta, A. (2024). Serum tumour necrosis factor-alpha as a marker of disease activity in children with nephrotic syndrome. Journal of Tropical Pediatrics. https://doi.org/10.1093/tropej/fmae025
Vancouver
Gowtham BC, Dawman L, Tiewsoh K, Kushwah S, Rawat A, Singh T, et al. Serum tumour necrosis factor-alpha as a marker of disease activity in children with nephrotic syndrome. Journal of Tropical Pediatrics. 2024. doi:10.1093/tropej/fmae025
BibTeX
@article{Gowtham2024,
author = {Gowtham, B C and Dawman, Lesa and Tiewsoh, Karalanglin and Kushwah, Sunil and Rawat, Amit and Singh, Thakurvir and Gupta, Aarchie},
title = {Serum tumour necrosis factor-alpha as a marker of disease activity in children with nephrotic syndrome},
journal = {Journal of Tropical Pediatrics},
year = {2024},
doi = {10.1093/tropej/fmae025}
}
EUVIMED